|Bid||11.68 x 800|
|Ask||11.76 x 1200|
|Day's Range||11.50 - 11.60|
|52 Week Range||11.33 - 16.13|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||-4.62|
|Expense Ratio (net)||1.07%|
The Employment Fund’s employee cooperation negotiations have ended. The total number of the personnel of the Employment Fund is currently 170 persons. The Employment Fund started its operations on 1 January 2019, when the Unemployment Insurance Fund and the Education Fund were merged.
The Employment Fund has given the Ministry of Social Affairs and Health an estimate according to which unemployment insurance contributions in 2020 would not exceed 3.00% or, in any case, would not decrease by more than 0.6 percentage points. The Employment Fund estimates that earnings-related benefit expenses and the government’s contribution would together amount to EUR 2,769 million in 2020, which would be approximately EUR 100 million more than in 2019. The Employment Fund has a legal obligation to submit an estimate of the following year’s earnings-related benefit expenses, the government’s contribution and percentages of workers’ contributions to the Ministry of Social Affairs and Health each year.
Employment Fund Stock Exchange Release 28 March 2019 at 12:00 Unemployment Insurance Fund's (TVR) Annual Report is published on 28 March 2019. Report.
Employment Fund commenced its operations 1 January 2019 when Unemployment Insurance Fund and Education Fund were merged. The negotiations are necessary to organize Employment fund according to the decisions made by the Board of Directors and to reach the relevant strategic and operational goals. The negotiations are covering the personnel of 168 persons. The aim of the employee cooperation negotiations is not to generate cost savings but rather to restructure the operations of the Fund according to the aforementioned goals.
Employment Fund Stock Exchange Release 29 January 2019 at 11:30 Employment Fund: Unemployment Insurance Fund`s (TVR) preliminary results ...
For much of 2018, the growth-fueled bull run has seen U.S. equities garner much of the attention compared to bonds--their less exciting capital markets brethren. After washing investors through October's volatility machine, the pattern continues to persist in the capital markets as the Dow Jones Industrial Average began Monday with a 600-point loss as it struggles to recover on Tuesday--a sign that investors should give bonds a closer look--fixed-income exchange-traded funds (ETFs) in particular. As such, traders looking to juice returns on leveraged plays in the Treasury debt space can look to ETFs like the Direxion Daily 7-10 Yr Treasury Bull 3X ETF (TYD) and Direxion Daily 7-10 Yr Treasury Bear 3X ETF (TYO) .
Large biotech companies are cashing in on small and mid-cap firms and investors should follow suit, experts say. Smaller biotech firms have hit huge paydays in 2018 as larger companies continue to add these firms' drugs to their own pipelines, expanding their clinical assets. Global acquisitions of biotech companies are expected to be at the highest annual level in 12 years, according to Bloomberg data.